- call +1-201-465-4211
- email sales@mrinsights.biz
Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
Scope of the Report:
This report focuses on the Paclitaxel-eluting Stent in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Paclitaxel-eluting Stent is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Metal Stent
Polymer Stent
Others
Market Segment by Applications, can be divided into
Coronary Heart Disease
Clinical
Others
There are 15 Chapters to deeply display the global Paclitaxel-eluting Stent market.
Chapter 1, to describe Paclitaxel-eluting Stent Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Paclitaxel-eluting Stent, with sales, revenue, and price of Paclitaxel-eluting Stent, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Paclitaxel-eluting Stent, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Paclitaxel-eluting Stent market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Paclitaxel-eluting Stent sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Paclitaxel-eluting Stent Introduction
1.2 Market Analysis by Type
1.2.1 Metal Stent
1.2.2 Polymer Stent
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Coronary Heart Disease
1.3.2 Clinical
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 B.Braun Melsengen AG
2.1.1 Business Overview
2.1.2 Paclitaxel-eluting Stent Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biosensors
2.2.1 Business Overview
2.2.2 Paclitaxel-eluting Stent Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biosensors Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biotronik
2.3.1 Business Overview
2.3.2 Paclitaxel-eluting Stent Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biotronik Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Blue Medical
2.4.1 Business Overview
2.4.2 Paclitaxel-eluting Stent Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Blue Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boston Scientific
2.5.1 Business Overview
2.5.2 Paclitaxel-eluting Stent Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boston Scientific Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 DISA Vascular
2.6.1 Business Overview
2.6.2 Paclitaxel-eluting Stent Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 DISA Vascular Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Essen
2.7.1 Business Overview
2.7.2 Paclitaxel-eluting Stent Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Essen Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medtronic Vascular
2.8.1 Business Overview
2.8.2 Paclitaxel-eluting Stent Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 MicroPort Medical
2.9.1 Business Overview
2.9.2 Paclitaxel-eluting Stent Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 MicroPort Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Terumo Medical
2.10.1 Business Overview
2.10.2 Paclitaxel-eluting Stent Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Terumo Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Orbusneich
2.11.1 Business Overview
2.11.2 Paclitaxel-eluting Stent Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Orbusneich Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Paclitaxel-eluting Stent Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Paclitaxel-eluting Stent Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Paclitaxel-eluting Stent Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Paclitaxel-eluting Stent Manufacturer Market Share in 2017
3.3.2 Top 6 Paclitaxel-eluting Stent Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Paclitaxel-eluting Stent Market Analysis by Regions
4.1 Global Paclitaxel-eluting Stent Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel-eluting Stent Sales and Market Share by Regions (2013-2018)
4.1.2 Global Paclitaxel-eluting Stent Revenue and Market Share by Regions (2013-2018)
4.2 North America Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
4.3 Europe Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
4.5 South America Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
5 North America Paclitaxel-eluting Stent by Countries
5.1 North America Paclitaxel-eluting Stent Sales, Revenue and Market Share by Countries
5.1.1 North America Paclitaxel-eluting Stent Sales and Market Share by Countries (2013-2018)
5.1.2 North America Paclitaxel-eluting Stent Revenue and Market Share by Countries (2013-2018)
5.2 United States Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
5.3 Canada Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
5.4 Mexico Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
6 Europe Paclitaxel-eluting Stent by Countries
6.1 Europe Paclitaxel-eluting Stent Sales, Revenue and Market Share by Countries
6.1.1 Europe Paclitaxel-eluting Stent Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Paclitaxel-eluting Stent Revenue and Market Share by Countries (2013-2018)
6.2 Germany Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
6.3 UK Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
6.4 France Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
6.5 Russia Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
6.6 Italy Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
7 Asia-Pacific Paclitaxel-eluting Stent by Countries
7.1 Asia-Pacific Paclitaxel-eluting Stent Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Paclitaxel-eluting Stent Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Market Share by Countries (2013-2018)
7.2 China Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
7.3 Japan Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
7.4 Korea Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
7.5 India Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
8 South America Paclitaxel-eluting Stent by Countries
8.1 South America Paclitaxel-eluting Stent Sales, Revenue and Market Share by Countries
8.1.1 South America Paclitaxel-eluting Stent Sales and Market Share by Countries (2013-2018)
8.1.2 South America Paclitaxel-eluting Stent Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
8.3 Argentina Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
8.4 Colombia Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
9 Middle East and Africa Paclitaxel-eluting Stent by Countries
9.1 Middle East and Africa Paclitaxel-eluting Stent Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Paclitaxel-eluting Stent Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Paclitaxel-eluting Stent Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
9.3 UAE Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
9.4 Egypt Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
9.5 Nigeria Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
9.6 South Africa Paclitaxel-eluting Stent Sales and Growth Rate (2013-2018)
10 Global Paclitaxel-eluting Stent Market Segment by Type
10.1 Global Paclitaxel-eluting Stent Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Paclitaxel-eluting Stent Sales and Market Share by Type (2013-2018)
10.1.2 Global Paclitaxel-eluting Stent Revenue and Market Share by Type (2013-2018)
10.2 Metal Stent Sales Growth and Price
10.2.1 Global Metal Stent Sales Growth (2013-2018)
10.2.2 Global Metal Stent Price (2013-2018)
10.3 Polymer Stent Sales Growth and Price
10.3.1 Global Polymer Stent Sales Growth (2013-2018)
10.3.2 Global Polymer Stent Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Paclitaxel-eluting Stent Market Segment by Application
11.1 Global Paclitaxel-eluting Stent Sales Market Share by Application (2013-2018)
11.2 Coronary Heart Disease Sales Growth (2013-2018)
11.3 Clinical Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.1 Global Paclitaxel-eluting Stent Sales, Revenue and Growth Rate (2018-2023)
12.2 Paclitaxel-eluting Stent Market Forecast by Regions (2018-2023)
12.2.1 North America Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.2.2 Europe Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.2.3 Asia-Pacific Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.2.4 South America Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.2.5 Middle East and Africa Paclitaxel-eluting Stent Market Forecast (2018-2023)
12.3 Paclitaxel-eluting Stent Market Forecast by Type (2018-2023)
12.3.1 Global Paclitaxel-eluting Stent Sales Forecast by Type (2018-2023)
12.3.2 Global Paclitaxel-eluting Stent Market Share Forecast by Type (2018-2023)
12.4 Paclitaxel-eluting Stent Market Forecast by Application (2018-2023)
12.4.1 Global Paclitaxel-eluting Stent Sales Forecast by Application (2018-2023)
12.4.2 Global Paclitaxel-eluting Stent Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Paclitaxel-eluting Stent Picture
Table Product Specifications of Paclitaxel-eluting Stent
Figure Global Sales Market Share of Paclitaxel-eluting Stent by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
